Skip to search formSkip to main contentSkip to account menu

NAX 5055

Known as: NAX-5055 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

GalaninLipopeptides
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Epilepsy: the next generation drugs (a review)
Epilepsy is a disease characterized by spontaneous recurrence of unprovoked seizures. Seizures and epilepsy are different… 
2017
2017
The novel anticonvulsant neuropeptide and galanin analogue, NAX‐5055, does not alter energy and amino acid metabolism in cultured brain cells
A large body of evidence suggests that the neuropeptide galanin plays an important role in seizure control. In line with this, it… 
2016
2016
The anticonvulsant action of the galanin receptor agonist NAX-5055 involves modulation of both excitatory- and inhibitory neurotransmission
2015
2015
Regulation of glucose and insulin release following acute and repeated treatment with the synthetic galanin analog NAX-5055
2015
2015
Galanin regulates blood glucose level in the zebrafish: a morphological and functional study
The present study has demonstrated the galaninergic innervation of the endocrine pancreas including sources of the galaninergic… 
2014
2014
Efficacy and tolerability of the galanin analog NAX 5055 in the multiple-hit rat model of symptomatic infantile spasms
Review
2010
Review
2010
Progress report on new antiepileptic drugs: A summary of the Tenth Eilat Conference (EILAT X)
Review
2009
Review
2009
Progress report on new antiepileptic drugs: A summary of the Ninth Eilat Conference (EILAT IX)
2009
2009
Developing novel antiepileptic drugs: Characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)